You are here


One of AdvaMed’s strategic priorities is the development of a robust research agenda highlighting key analyses and evidence on the value of medical technology; the impact of harmful regulations such as the medical device tax and harsh payment/coverage policies; and the economic value of technology investment.

This data-driven guidance helps AdvaMed support policy formation and shape new delivery systems. Below are recent studies developed as part of AdvaMed’s research agenda as well as external studies of significance.